Early discharge on postoperative day 1 following lobectomy for stage I non-small-cell lung cancer is safe in high-volume surgical centres: a national cancer database analysis

Author:

Drawbert Hans E1ORCID,Hey Matthew T1ORCID,Tarrazzi Francisco1,Block Mark1ORCID,Razi Syed S12

Affiliation:

1. Herbert Wertheim College of Medicine, Florida International University, Miami, FL, USA

2. Division of Thoracic Surgery, Memorial Healthcare System, Pembroke Pines, FL, USA

Abstract

Abstract OBJECTIVES Shortening hospital length of stay after lobectomy for stage I non-small-cell lung cancer (NSCLC) remains a challenge, and the literature regarding factors associated with safe early discharge is limited. We sought to evaluate the safety of postoperative day (POD) 1 discharge after lobectomy and its correlation with institutional caseload using the National Cancer Database, jointly sponsored by the American College of Surgeons and the American Cancer Society. METHODS We identified patients with stage I NSCLC (tumour ≤4 cm, clinical N0, M0) in the National Cancer Database who underwent lobectomy from 2010 to 2015. Hospital surgical volume was assigned based on total surgical volume for lung cancer. The cohort was divided into 2 groups: POD 1 discharge [length of stay (LOS) ≤ 1] and the standard discharge (LOS > 1). Outcome variables were compared in propensity matched cohorts, and the multivariable regression model was created to assess factors associated with LOS ≤ 1 and the occurrence of adverse events (unplanned readmissions, 30- and 90-day deaths). RESULTS A total of 52 830 patients underwent lobectomy for stage I NSCLC across 1231 treating facilities; 3879 (7.3%) patients were discharged on day 1 (LOS ≤ 1), whereas 48 951 (92.7%) were discharged after day 1 (LOS > 1). Factors associated with LOS ≤ 1 included male sex, higher socioeconomic status, right middle lobectomy, minimally invasive surgery and high-volume centres. The risk of adverse events was higher for LOS ≤ 1 in low [odds ratio (OR): 1.913, 95% confidence interval (CI) 1.448–2.527; P < 0.001] and median quartiles (OR: 2.258; 95% CI 1.881–2.711; P < 0.001), but equivalent in high-volume centres (OR: 0.871, 95% CI 0.556–1.364; P = 0.54). CONCLUSIONS The safety and efficacy of early discharge on POD 1 following lobectomy are associated with lung cancer surgical volume. Implementation of ‘enhanced recovery’ protocols is likely related to safe early discharges from high-volume centres.

Publisher

Oxford University Press (OUP)

Subject

Cardiology and Cardiovascular Medicine,Pulmonary and Respiratory Medicine,General Medicine,Surgery

Reference18 articles.

1. Length of stay from the hospital perspective;Rosen;Ann Surg,2017

2. Postoperative day 1 discharge after anatomic lung resection: a Society of Thoracic Surgeons database analysis;Linden;J Thorac Cardiovas Surg,2020

3. Early discharge does not increase readmission rates after minimally invasive anatomic lung resection innovations: technology and techniques in cardiothoracic and vascular;Chevrollier;Surgery,2019

4. Early discharge after lung resection is safe: 10-year experience;Towe;J Thorac Dis,2018

5. Publication trend, resource utilization, and impact of the US National Cancer Database: a systematic review;Su;Medicine (Baltimore),2018

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3